Transitional Cell Cancer of the Renal Pelvis and Ureter [clinicaltrials_resource:0d14490145d37f65682966d5ad1dc92e]
Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [clinicaltrials:NCT00002914]Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer [clinicaltrials:NCT00003105]Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer [clinicaltrials:NCT00003133]Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer [clinicaltrials:NCT00003175]Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer [clinicaltrials:NCT00003342]Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [clinicaltrials:NCT00003376]Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer [clinicaltrials:NCT00003520]clinicaltrials:NCT00004203Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer [clinicaltrials:NCT00004223]Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function [clinicaltrials:NCT00005644]Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer [clinicaltrials:NCT00005958]Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract [clinicaltrials:NCT00006026]Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract [clinicaltrials:NCT00006111]SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract [clinicaltrials:NCT00006351]R115777 in Treating Patients With Advanced Bladder Cancer [clinicaltrials:NCT00006376]clinicaltrials:NCT00014144Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium [clinicaltrials:NCT00014274]Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer [clinicaltrials:NCT00022191]clinicaltrials:NCT00022633Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer [clinicaltrials:NCT00028860]clinicaltrials:NCT00045630clinicaltrials:NCT00053209Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter [clinicaltrials:NCT00066352]clinicaltrials:NCT00066612clinicaltrials:NCT00080795clinicaltrials:NCT00087295Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium [clinicaltrials:NCT00310011]clinicaltrials:NCT00397488Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer [clinicaltrials:NCT00623064]Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom [clinicaltrials:NCT00757614]Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer [clinicaltrials:NCT00792025]Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants [clinicaltrials:NCT00900276]Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment [clinicaltrials:NCT01031875]clinicaltrials:NCT01089088Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium [clinicaltrials:NCT01090466]Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer [clinicaltrials:NCT01118039]clinicaltrials:NCT01191892
condition [clinicaltrials_vocabulary:condition]
Transitional Cell Cancer of the Renal Pelvis and Ureter [clinicaltrials_resource:0d14490145d37f65682966d5ad1dc92e]
Bio2RDF identifier
0d14490145d37f65682966d5ad1dc92e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0d14490145d37f65682966d5ad1dc92e
identifier
clinicaltrials_resource:0d14490145d37f65682966d5ad1dc92e
title
Transitional Cell Cancer of the Renal Pelvis and Ureter
@en
label
Transitional Cell Cancer of th ...... 4490145d37f65682966d5ad1dc92e]
@en